Ed Prideaux

Chemical Collective • 3rd October 2025

Non-Consensual Dosing in Psychedelic History | Chemical Collective

Today, we all accept that dosing people with psychedelic drugs is wrong. But this cannot be taken for granted, for it was an extremely popular practice in the 1960s. Some would theorise, for instance, that the 1960s began as a cultural phenomenon with a particular spiking incident in 1965 – around whose aftermath the whole Generation’s predatory character can be understood.

Chemical Collective • 17th September 2025

Beyond Blue Mondays: The Problem of Post-Psychedelic Depression | Chemical Collective

The day after a psychedelic trip is often described in two very different ways. For some, there’s the “afterglow”: a lingering sense of joy and clarity that can last days or even weeks. But there’s also a lesser-acknowledged counterpart: the psychedelic hangover, which may accompany an afterglow in some mitigated form. This can mean feeling drained, irritable, foggy, or emotionally flat in the hours or days after a session.  Sometimes, this dark mood doesn't stop, and people develop debilitating depressive disorders.

Chemical Collective • 13th September 2025

Cracking the Doors of Perception | Chemical Collective

Some people who take psychedelic drugs remain in prolonged psychotic states for weeks, months or years. What do we know about how it works? And what does it feel like?

Ecstatic Integration • 12th September 2025

Everything you ever wanted to know about ketamine

Ketamine is the drug of the 21st-century. Here is a guide that I contributed to, primarily authored by the philosopher and researcher Jules Evans.

Chemical Collective • 22nd August 2025

Tripping in the Material World: A Historical Materialist Analysis of Psychedelia | Chemical Collective

"It is not consciousness that determines life, but life that determines consciousness", wrote Marx and Engels. How much is 'the' 'psychedelic experience' shaped and conditioned by material economic forces?

Chemical Collective • 6th July 2025

I've Tried, But I Still Don't Know What 'Mustard Lies' Is Supposed To Mean | Chemical Collective

The Smashing Pumpkins are rarely filed alongside the great psychedelic bands. It’s not hard to see why.

Chemical Collective • 3rd June 2025

Icarus on Acid: On the Phenomenon of Leaps and Falls from Heights Involving Psychedelics | Chemical Collective

For seventy years, people high on psychedelic drugs have leapt from windows and balconies to grave injury and death. Why?

24th April 2025

A trip too far: The LSD experience that blew up the Huxley family

How Britain's most famous intellectual family hit the rocks one intense acid-drenched night in Connecticut

26th February 2025

Unreality Beyond The Patient

Derealisation has primarily been seen as an individual pathology, often linked to trauma or extreme stress. But the digitisation of everyday life and the increasing abstraction of government have transformed it into a collective affliction.

13th February 2025

Notes on Nihilistic Psychedelia

When everything is a game, it's possible you might get played

New Statesman • 1st February 2025

Inside the psychedelic elite

When a mother spikes their emotionally disturbed child with large quantities of class-A drugs, the response is not often sympathetic. Yet Paul Stamets – a fungus expert and wildly popular psychedelics advocate who is fond of appearing on Joe Rogan’s podcast wearing a mushroom hat – is choked with emotion when telling the story, which he received via anonymous email, and recalled following a question about the possible role of psychedelics in paediatric medicine.

29th January 2025

The dark wisdom of herem

Total destruction in an age of technology.

21st January 2025

Glitchcraft: The Tale of Leilan and Peter Todd

ChatGPT has spontaneously created two mythological archetypes through ‘glitch tokens’ - an evil wizard called petertodd and a nurturing goddess called Leilan. The self-generated religion is attracting devotees in the real world, a possible HBO documentary, and even its own traded crypto token.

28th December 2024

Cracking The Code

A Russian-born video editor claims that gazing at a laser projection while on DMT reveals the 'Code of Reality'. Why are so many people interested?

The Bigger Picture • 23rd February 2024

True Detective and the Challenge of Nihilism

An exploration of the dialectic between Christianity and Nihilism, as presented through the critically-acclaimed first season of True Detective, which turned ten in February 2024.

Ecstatic Integration • 25th January 2024

Psychedelic therapy & the Metaphysical Menu

I examine a proposal in psychedelic-assisted therapy to present a 'menu' of different metaphysical beliefs for clients to ponder in assisting the aftermath of their dosing sessions. Is metaphysical truth an appropriate domain for therapy? Are psychedelics useful as tools of metaphysical illumination? And does presenting a 'menu' encourage the idea that we can 'pick and choose' what's true like philosophical consumers?

Ecstatic Integration • 19th January 2024

Was Marcia Moore murdered?

Part two of my exploratory series into the mysterious death of the heiress, yoga pioneer and ketamine advocate Marcia Moore.

Ecstatic Integration • 16th January 2024

The mysterious death of the ketamine priestess

Marcia Moore disappeared in the winter of 1979 in circumstances that remain mysterious. Her disappearance came after publishing one of the West's first paeans to the now popular psychedelic dissociative-cum-antidepressant ketamine, which she hailed as a Goddess to access the Jungian unconscious and states of enlightenment.

BBC • 2nd November 2023

Psilocybin and LSD: What I learnt after experiencing 'psychedelic flashbacks'

I discuss the culture, psychology and neurology of Hallucinogen Persisting Perception Disorder (HPPD). The piece includes an overview of my MSc research, which evidenced the considerable cognitive and behavioural components of the disorder alongside its direct symptoms.

Psychedelics Today • 30th October 2023

Real Harm Reduction Requires Redistribution of Wealth

How do we help people who have developed debilitating problems from psychedelic drugs? Since accessing help is so often a matter of the money to pay for it, I ask whether psychedelia's billionaire philanthropists should provide direct cash transfers to its poorest.